Role of HIF-1α-Activated IL-22/IL-22R1/Bmi1 Signaling Modulates the Self-Renewal of Cardiac Stem Cells in Acute Myocardial Ischemia
Stem Cell Reviews and Reports · 2024
DOI: 10.1007/s12015-024-10774-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reviews and Reports, 2024. Verfasst von Wei Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cell Therapy Center, China Medical University Hospital (CMUH), Taichung, 404, Taiwan. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Interleukin-22, Signal Transduction, Interleukins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and Technology, Taiwan.
Abstract (Originalsprache)
Impaired tissue regeneration negatively impacts on left ventricular (LV) function and remodeling after acute myocardial infarction (AMI). Little is known about the intrinsic regulatory machinery of ischemia-induced endogenous cardiac stem cells (eCSCs) self-renewing divisions after AMI. The interleukin 22 (IL-22)/IL-22 receptor 1 (IL-22R1) pathway has emerged as an important regulator of several cellular processes, including the self-renewal and proliferation of stem cells. However, whether the hypoxic environment could trigger the self-renewal of eCSCs via IL-22/IL-22R1 activation remains unknown. In this study, the upregulation of IL-22R1 occurred due to activation of hypoxia-inducible factor-1α (HIF-1α) under hypoxic and ischemic conditions. Systemic IL-22 administration not only attenuated cardiac remodeling, inflammatory responses, but also promoted eCSC-mediated cardiac repair after AMI. Unbiased RNA microarray analysis showed that the downstream mediator Bmi1 regulated the activation of CSCs. Therefore, the HIF-1α-induced IL-22/IL-22R1/Bmi1 cascade can modulate the proliferation and activation of eCSCs in vitro and in vivo. Collectively, investigating the HIF-1α-activated IL-22/IL-22R1/Bmi1 signaling pathway might offer a new therapeutic strategy for AMI via eCSC-induced cardiac repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cell Therapy Center, China Medical University Hospital (CMUH), Taichung, 404, Taiwan.
- Translational Medicine Research Center, CMUH, Taichung, 404, Taiwan.
- Graduate Institute of Biomedical Sciences, China Medical University (CMU), Taichung, 404, Taiwan.
- Neuroscience and Brain Disease Center and New Drug Development Center, CMU, Taichung, 404, Taiwan.
- Regenerative Medicine Research Group, Institute of Cellular and System Medicine, National Health Research Institutes (NHRI), Zhunan, 350, Taiwan.
- Graduate Institute of Biomedical Sciences and Research Centers for Cancer Biology and Molecular Medicine, CMU, Taichung, 404, Taiwan.
ORCID-Profile: Woei-Cherng Shyu
Förderung
- Ministry of Science and Technology, Taiwan
Zitieren
APA
Lee, W., Lin, S. L., Chiang, C. S., Chen, J. Y., Chieng, W. W., Huang, S. R., Chang, T. Y., Linju Yen, B., Hung, M. C., Chang, K. C., Lee, H. T., Jeng, L. B., & Shyu, W. C. (2024). Role of HIF-1α-Activated IL-22/IL-22R1/Bmi1 Signaling Modulates the Self-Renewal of Cardiac Stem Cells in Acute Myocardial Ischemia. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-024-10774-8
Vancouver
Lee W, Lin SL, Chiang CS, Chen JY, Chieng WW, Huang SR, et al. Role of HIF-1α-Activated IL-22/IL-22R1/Bmi1 Signaling Modulates the Self-Renewal of Cardiac Stem Cells in Acute Myocardial Ischemia. Stem Cell Reviews and Reports. 2024. doi:10.1007/s12015-024-10774-8
BibTeX
@article{Lee2024,
author = {Lee, Wei and Lin, Syuan-Ling and Chiang, Chih-Sheng and Chen, Jui-Yu and Chieng, Wee-Wei and Huang, Shu-Rou and Chang, Ting-Yu and Linju Yen, B and Hung, Mien-Chie and Chang, Kuan-Cheng and Lee, Hsu-Tung and Jeng, Long-Bin and Shyu, Woei-Cherng},
title = {Role of HIF-1α-Activated IL-22/IL-22R1/Bmi1 Signaling Modulates the Self-Renewal of Cardiac Stem Cells in Acute Myocardial Ischemia},
journal = {Stem Cell Reviews and Reports},
year = {2024},
doi = {10.1007/s12015-024-10774-8}
}
EUVIMED